PTPN12 and colorectal carcinoma: Notably, PTPN12 protein was overexpressed in oxaliplatin-resistant CRC cells, and its inhibition restored chemosensitivity in in vitro models.​.<h4>Conclusion</h4>PTPN12 shows promise as a potential biomarker and therapeutic target candidate in CRC.